Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Running

BRAINSTORM Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials

Coordinator
Friedrich-Alexander-Universitaet Erlangen-Nuernberg, Germany
Runs
1 April 2023 to 31 March 2027
Status
Running
EU funding
€3.1m
Total cost
€3.1m
Partners
8 organisations in 7 countries
Type
European Innovation Council
Grant agreement
101099355

What the project is doing

In the project's own words, from its summary on CORDIS.

BRAINSTORM will introduce an innovative, scalable, wireless, multimodal nanoinvasive neuromodulation technology suitable for independent and switchable excitation and inhibition of deep brain neurons. BRAINSTORM breakthrough relies on novel smart anisotropic magnetic nanomaterials (SMNs) acting both as nanoscale ‘heaters’ and as ‘torquers’ by leveraging either hysteretic losses under kHz frequencies or transitions from vortex to in-plane magnetization under Hz frequencies.

Intrinsic bimodal functionality that permits direct control of thermosensitive or mechanosenitive neurons, will be boosted by advanced polymer functionalization to transfer torques to electrical signals trough piezoelectric coating, and to enable transport and delivery of viral vectors to targeted neurons for genetic targeting with sensory channels. SMNs will also be steered to endogenous sensory channels relying on antibody targeting.

Selected actuation of ion channels that respond to thermal or mechanical stimulus will permit selective activation or inhibition of targeted neuronal populations identifiable by magnetic resonance imaging. Advanced driving electronics will include to metamaterial solenoid coils for rapid frequency switch for control of ‘mechanical’ or ‘thermal’ functionality while focused ultrasound will facilitate non invasive delivery of SMNs in the targeted brain area.

The ability of the BRAINSTORM platform to shape behaviour and demonstrate therapeutic potential by modulating the excitation/inhibition balance through thermal/mechanical/electrical modalities will be demonstrated in mouse models of Fragile X syndrome.

Who is involved

OrganisationCityCountryRole
Friedrich-Alexander-Universitaet Erlangen-NuernbergErlangenGermanyCoordinator
Asociacion Centro De Investigacion Cooperativa En Biomateriales- Cic BiomaguneSan SebastianSpainParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Valo Therapeutics OyHelsinkiFinlandParticipant
Sveuciliste U Zagrebu Fakultet Elektrotehnike I RacunarstvaZagrebCroatiaParticipant
Universita Degli Studi Di Roma Tor VergataRomaItalyParticipant
Percuros BV's-Gravenhage (Den Haag)NetherlandsParticipant
University of GlasgowGlasgowUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI